Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint

Ted R Mikuls1,2, Michael J Duryee1,2, Rafid Rahman2

  • 1Veteran Affairs Nebraska-Western Iowa Health Care System.

Abstract

Insights

Malondialdehyde-acetaldehyde (MAA) adducts and anti-MAA antibodies are elevated in rheumatoid arthritis (RA) joints. These findings suggest MAA adducts contribute to local autoantibody production in RA.

Area of Science:

  • Rheumatology
  • Immunology
  • Biochemistry

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
  • The role of specific adducts, such as malondialdehyde-acetaldehyde (MAA), and their corresponding antibodies in RA pathogenesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the expression of MAA adducts and anti-MAA antibodies in the synovial tissues and serum of patients with RA.
  • To compare these markers between RA and osteoarthritis (OA) patients.

Main Methods:

  • Analysis of paired serum and synovial fluid (SF) samples from RA and OA patients.
  • Quantification of anti-MAA antibodies, rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), and total immunoglobulin.
  • Immunohistochemical examination of synovial tissues for MAA adducts, citrulline, and leukocyte markers.

Main Results:

  • Anti-MAA antibody concentrations were significantly higher in RA serum and SF compared to OA.
  • IgG, IgM, and IgA anti-MAA antibodies were enriched in RA SF relative to serum.
  • MAA adducts co-localized with citrulline and B cells (CD19+, CD27+) in RA synovial tissues, more so than with T cells or monocytes.

Conclusions:

  • Anti-MAA antibodies show local enrichment within the RA joint, unlike other autoantibodies.
  • The co-localization of MAA adducts and citrulline with B cells suggests MAA adducts play a role in local autoantibody production in RA.